Click on the slide!

Explore and Learn

Learn more about the cause of Cystinosis, genetics and genetic testing, carrier status, and care and management for you or your family member.

Click on the slide!

Understand Clinical Trials

Learn more about ongoing and upcoming clinical trials, the clinical trial process, and what is involved in participating in a clinical trial.

Click on the slide!

Explore and Learn

Learn more about the cause of Cystinosis, genetics and genetic testing, carrier status, and care and management for you or your family member.

Click on the slide!

Are you a Professional?

Access the Professional Portal to access current treatment/genetic testing data, perform assisted searches for study/trial development, and access educational materials.

More...
Frontpage Slideshow (version 2.0.0) - Copyright © 2006-2008 by JoomlaWorks

PROCYSBI Receives FDA Approval in the U.S.

E-mail Print PDF
CCIR is pleased to share with you breaking news from Raptor Pharmaceutical regarding U.S. FDA approval of the drug PROCYSBI. This is a delayed release formulation of cysteamine bitratrate for the treatment of cystinosis. The drug is prescribed for administration every 12 hours compared to every 6 hours for Cystagon. Please follow either of the links below to read more.

CCIR Supporters